Biorecycling platform Epoch Biodesign has signed for space at Kadans Science Partners’ recently completed MAYDE lab and research facility in the Tileyard Quarter at King’s Cross.
The company is expanding its London presence, taking office and lab space at the new 114,000 sq ft state-of-the-art building.
Jacob Nathan, founder and CEO of Epoch Biodesign, said: “We’re excited to grow our facilities and footprint in London. MAYDE provides an excellent space for us to expand our chemistry and mid-scale production capabilities.”
Katie Nelson, head of leasing UK and Ireland at Kadans Science Partner, added:“Kadans creates environments in which scientific organisations can thrive and Epoch Biodesign’s decision to take space at our MAYDE facility is a great example of that happening in action. MAYDE will provide Epoch with providing tailored space that can grow with them as their requirements evolve.
“With its comprehensive facilities and close proximity to other companies within King’s Cross’ life science cluster, we are excited to continue welcoming other leading biotech and life science companies to MAYDE and allow us to become part of their growth journey within this thriving community.”
DTRE and Savills acted on behalf of Kadans Science Partner.
